NCT04034901

Brief Summary

Background : Acute exacerbations of COPD (Chronic Obstructive Pulmonary Disease) are frequent events in the course of the disease and they can deteriorate the respiratory function of the patients, impact their quality of life and even potentially threaten their life. It is therefore crucial to prevent these exacerbations from occurring. Aim of the study : Investigate how cardiorespiratory parameters of COPD patients differ between exacerbation phases and their nominal state in order to identify predictors of COPD exacerbations. Study design : Patients admitted at one of the investigation centers on a suspicion of COPD exacerbation will be enrolled on a voluntary basis. Enrolled patients' cardiorespiratory parameters will be monitored with a connected wrist-worn pulse oximeter (BORA Band) during the hospitalisation phase and one month after they have been discharged. Setting : 4 investigative centers across Brittany Patients : 50 patients will be enrolled in the study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2019

Completed
28 days until next milestone

First Posted

Study publicly available on registry

July 26, 2019

Completed
1.6 years until next milestone

Study Start

First participant enrolled

February 19, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 6, 2024

Completed
Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

3 years

First QC Date

June 28, 2019

Last Update Submit

August 14, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Variation of heart rate during and after a COPD acute exacerbation

    Average heart rate in beats per minute during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter

    2 months

  • Variation of respiratory rate during and after a COPD acute exacerbation

    Average respiratory rate in cycles per minute during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter

    2 months

  • Variation of SpO2 during and after a COPD acute exacerbation

    Average SpO2 in percent during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter

    2 months

  • Variation of skin temperature during and after a COPD acute exacerbation

    Average skin temperature in celcius during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter

    2 months

  • Variation of patient activity during and after a COPD acute exacerbation

    Average patient activity measured in activity duration per day during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter

    2 months

Secondary Outcomes (2)

  • Connected wrist-worn pulse oximeter adherence

    2 months

  • Patient satisfaction

    2 months

Study Arms (1)

Monitoring of cardiorespiratory parameters

EXPERIMENTAL

Monitoring of cardiorespiratory parameters with BORA Band

Device: Monitoring of cardiorespiratory parameters with BORA Band

Interventions

The subjects will continuously wear a connected wrist-worn pulse oximeter which will remotely collect the following measurements : * Activity * Step count * Heart rate * Respiratory rate * Skin temperature * SpO2

Monitoring of cardiorespiratory parameters

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient known or suspected to suffer from COPD
  • patient admitted in pulmonology unit for COPD exacerbation
  • patient accepting to use BORA Band during and after hospitalization
  • patient accepting to be followed by the partner health care provider for this study (Air de Bretagne)
  • patient able to understand French and express their informed consent
  • patient affiliated to social security

You may not qualify if:

  • patient is intubated
  • patient already followed by a health care provider other than Air de Bretagne
  • investigator assesses that the patient will have difficulties following the protocol
  • patient already enrolled in another interventional study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chru Pontchaillou

Rennes, 35000, France

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Graziella Brinchault, M.D.

    CHU Rennes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2019

First Posted

July 26, 2019

Study Start

February 19, 2021

Primary Completion

February 6, 2024

Study Completion

February 6, 2024

Last Updated

August 15, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations